TCMBANKGE000135 |
CXCR4 |
CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS |
C-X-C motif chemokine receptor 4 |
TCMBANKGE000196 |
FAS |
ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6 |
Fas cell surface death receptor |
TCMBANKGE000201 |
ESR1 |
ER; ESR; ESRA; ESTRR; Era; NR3A1 |
estrogen receptor 1 |
TCMBANKGE000212 |
GRIN1 |
GluN1; MRD8; NDHMSD; NDHMSR; NMD-R1; NMDA1; NMDAR1; NR1 |
glutamate ionotropic receptor NMDA type subunit 1 |
TCMBANKGE000219 |
CCR5 |
CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22 |
C-C motif chemokine receptor 5 |
TCMBANKGE000241 |
CASP8 |
ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 |
caspase 8 |
TCMBANKGE000264 |
ABCB1 |
ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 |
ATP binding cassette subfamily B member 1 |
TCMBANKGE000274 |
CCL2 |
GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF |
C-C motif chemokine ligand 2 |
TCMBANKGE000315 |
IL4 |
BCGF-1; BCGF1; BSF-1; BSF1; IL-4 |
interleukin 4 |
TCMBANKGE000316 |
IL5 |
EDF; IL-5; TRF |
interleukin 5 |
TCMBANKGE000403 |
ATF2 |
CRE-BP1; CREB-2; CREB2; HB16; TREB7 |
activating transcription factor 2 |
TCMBANKGE000408 |
CCR3 |
C C CKR3; CC-CKR-3; CD193; CKR 3; CKR3; CMKBR3 |
C-C motif chemokine receptor 3 |
TCMBANKGE000425 |
DRD1 |
DADR; DRD1A |
dopamine receptor D1 |
TCMBANKGE000449 |
CCK |
- |
cholecystokinin |
TCMBANKGE000521 |
PLCG1 |
NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1 |
phospholipase C gamma 1 |
TCMBANKGE000556 |
MAPK10 |
JNK3; JNK3A; PRKM10; SAPK1b; p493F12; p54bSAPK |
mitogen-activated protein kinase 10 |
TCMBANKGE000598 |
MDK |
ARAP; MK; NEGF2 |
midkine |
TCMBANKGE000633 |
ADRB2 |
ADRB2R; ADRBR; B2AR; BAR; BETA2AR |
adrenoceptor beta 2 |
TCMBANKGE000792 |
FASLG |
ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A |
Fas ligand |
TCMBANKGE000845 |
CCL4 |
ACT2; AT744.1; G-26; HC21; LAG-1; LAG1; MIP-1-beta; MIP1B; MIP1B1; SCYA2; SCYA4 |
C-C motif chemokine ligand 4 |
TCMBANKGE000857 |
AHSA1 |
AHA1; C14orf3; hAha1; p38 |
activator of HSP90 ATPase activity 1 |
TCMBANKGE000866 |
PRKCB |
PKC-beta; PKCB; PKCI(2); PKCbeta; PRKCB1; PRKCB2 |
protein kinase C beta |
TCMBANKGE000869 |
DRD2 |
D2DR; D2R |
dopamine receptor D2 |
TCMBANKGE000881 |
PLAT |
T-PA; TPA |
plasminogen activator, tissue type |
TCMBANKGE000903 |
PTGS1 |
COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS |
prostaglandin-endoperoxide synthase 1 |
TCMBANKGE000970 |
FASN |
FAS; OA-519; SDR27X1 |
fatty acid synthase |
TCMBANKGE000979 |
KDR |
CD309; FLK1; VEGFR; VEGFR2 |
kinase insert domain receptor |
TCMBANKGE001011 |
TNFSF10 |
APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL |
TNF superfamily member 10 |
TCMBANKGE001037 |
MMP2 |
CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1 |
matrix metallopeptidase 2 |
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001076 |
SOD2 |
GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD |
superoxide dismutase 2 |
TCMBANKGE001097 |
HIF1A |
HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 |
hypoxia inducible factor 1 subunit alpha |
TCMBANKGE001114 |
IL6 |
BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6 |
interleukin 6 |
TCMBANKGE001132 |
BAX |
BCL2L4 |
BCL2 associated X, apoptosis regulator |
TCMBANKGE001144 |
CD14 |
- |
CD14 molecule |
TCMBANKGE001148 |
VEGFA |
MVCD1; VEGF; VPF |
vascular endothelial growth factor A |
TCMBANKGE001154 |
CREB1 |
CREB; CREB-1 |
cAMP responsive element binding protein 1 |
TCMBANKGE001156 |
CASP3 |
CPP32; CPP32B; SCA-1 |
caspase 3 |
TCMBANKGE001161 |
IL2 |
IL-2; TCGF; lymphokine |
interleukin 2 |
TCMBANKGE001162 |
IFNG |
IFG; IFI |
interferon gamma |
TCMBANKGE001166 |
BCL2 |
Bcl-2; PPP1R50 |
BCL2 apoptosis regulator |
TCMBANKGE001176 |
CAT |
- |
catalase |
TCMBANKGE001191 |
GRIA1 |
GLUH1; GLUR1; GLURA; GluA1; HBGR1 |
glutamate ionotropic receptor AMPA type subunit 1 |
TCMBANKGE001197 |
FOS |
AP-1; C-FOS; p55 |
Fos proto-oncogene, AP-1 transcription factor subunit |
TCMBANKGE001201 |
MAPK3 |
ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK |
mitogen-activated protein kinase 3 |
TCMBANKGE001203 |
MAPK1 |
ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK |
mitogen-activated protein kinase 1 |
TCMBANKGE001326 |
SRD5A2 |
- |
steroid 5 alpha-reductase 2 |
TCMBANKGE001536 |
DLD |
DLDD; DLDH; E3; GCSL; LAD; OGDC-E3; PHE3 |
dihydrolipoamide dehydrogenase |
TCMBANKGE001943 |
ADRA1D |
ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 |
adrenoceptor alpha 1D |
TCMBANKGE002342 |
GNAI3 |
87U6; ARCND1 |
G protein subunit alpha i3 |
TCMBANKGE002699 |
TH |
DYT14; DYT5b; TYH |
tyrosine hydroxylase |
TCMBANKGE003157 |
CHRM2 |
HM2 |
cholinergic receptor muscarinic 2 |
TCMBANKGE003415 |
GATA3 |
HDR; HDRS |
GATA binding protein 3 |
TCMBANKGE003625 |
SLC6A4 |
5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT |
solute carrier family 6 member 4 |
TCMBANKGE003775 |
ARRB1 |
ARB1; ARR1 |
arrestin beta 1 |
TCMBANKGE004002 |
CAMKK2 |
CAMKK; CAMKKB |
calcium/calmodulin dependent protein kinase kinase 2 |
TCMBANKGE005288 |
PDYN |
ADCA; PENKB; SCA23 |
prodynorphin |
TCMBANKGE005296 |
ARL6IP5 |
DERP11; GTRAP3-18; HSPC127; JWA; PRAF3; Yip6b; addicsin; hp22; jmx |
ADP ribosylation factor like GTPase 6 interacting protein 5 |
TCMBANKGE005535 |
CHRM1 |
HM1; M1; M1R |
cholinergic receptor muscarinic 1 |
TCMBANKGE005653 |
GRIN2A |
EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A |
glutamate ionotropic receptor NMDA type subunit 2A |
TCMBANKGE005865 |
CAMK4 |
CaMK IV; CaMK-GR; CaMKIV; caMK |
calcium/calmodulin dependent protein kinase IV |
TCMBANKGE006438 |
PCSK1 |
BMIQ12; NEC1; PC1; PC3; SPC3 |
proprotein convertase subtilisin/kexin type 1 |
TCMBANKGE006869 |
PTGER3 |
EP3; EP3-I; EP3-II; EP3-III; EP3-IV; EP3-VI; EP3e; PGE2-R; lnc003875 |
prostaglandin E receptor 3 |
TCMBANKGE006943 |
CHRM3 |
EGBRS; HM3; PBS |
cholinergic receptor muscarinic 3 |
TCMBANKGE007368 |
GSTP1 |
DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI |
glutathione S-transferase pi 1 |
TCMBANKGE007855 |
FCAMR |
CD351; FCA/MR; FKSG87 |
Fc fragment of IgA and IgM receptor |
TCMBANKGE008012 |
MAP2 |
MAP-2; MAP2A; MAP2B; MAP2C |
microtubule associated protein 2 |
TCMBANKGE008163 |
GRIN3A |
GluN3A; NMDAR-L; NMDAR3A; NR3A |
glutamate ionotropic receptor NMDA type subunit 3A |
TCMBANKGE008702 |
OPRM1 |
LMOR; M-OR-1; MOP; MOR; MOR1; OPRM |
opioid receptor mu 1 |
TCMBANKGE008743 |
OPRK1 |
K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK |
opioid receptor kappa 1 |
TCMBANKGE009455 |
CHRM5 |
HM5 |
cholinergic receptor muscarinic 5 |
TCMBANKGE009527 |
GADL1 |
ADC; CSADC; HuADC; HuCSADC |
glutamate decarboxylase like 1 |
TCMBANKGE009924 |
ADCY8 |
AC8; ADCY3; HBAC1 |
adenylate cyclase 8 |
TCMBANKGE009956 |
LITAF |
PIG7; SIMPLE; TP53I7 |
lipopolysaccharide induced TNF factor |
TCMBANKGE010467 |
MC4R |
BMIQ20 |
melanocortin 4 receptor |
TCMBANKGE010770 |
PCSK2 |
NEC 2; NEC-2; NEC2; PC2; SPC2 |
proprotein convertase subtilisin/kexin type 2 |
TCMBANKGE010995 |
GUSB |
BG; MPS7 |
glucuronidase beta |
TCMBANKGE011468 |
DLG4 |
MRD62; PSD95; SAP-90; SAP90 |
discs large MAGUK scaffold protein 4 |
TCMBANKGE011923 |
CHRM4 |
HM4; M4R |
cholinergic receptor muscarinic 4 |
TCMBANKGE012410 |
ARC |
Arg3.1; hArc |
activity regulated cytoskeleton associated protein |
TCMBANKGE013286 |
DLAT |
DLTA; E2; PBC; PDC-E2; PDCE2 |
dihydrolipoamide S-acetyltransferase |
TCMBANKGE013309 |
SLC17A7 |
BNPI; VGLUT1 |
solute carrier family 17 member 7 |
TCMBANKGE013550 |
NDUFS1 |
CI-75Kd; CI-75k; MC1DN5; PRO1304 |
NADH:ubiquinone oxidoreductase core subunit S1 |
TCMBANKGE013929 |
GNA12 |
NNX3; RMP; gep |
G protein subunit alpha 12 |
TCMBANKGE014322 |
IL23A |
IL-23; IL-23A; IL23P19; P19; SGRF |
interleukin 23 subunit alpha |
TCMBANKGE014423 |
ADRA1A |
ADRA1C; ADRA1L1; ALPHA1AAR |
adrenoceptor alpha 1A |
TCMBANKGE014473 |
CRH |
CRF; CRH1 |
corticotropin releasing hormone |
TCMBANKGE014625 |
OPRD1 |
DOP; DOR; DOR1; OPRD |
opioid receptor delta 1 |
TCMBANKGE014904 |
DBI |
ACBD1; ACBP; CCK-RP; EP |
diazepam binding inhibitor, acyl-CoA binding protein |